Activation of p38α in T cells regulates the intestinal host defense against attaching and effacing bacterial infections

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2764-2770

  Shim, Eun Jin ^a   Bang, Bo Ram ^a   Kang, Seung Goo ^a   Ma, Jianhui ^a   Otsuka, Motoyuki ^b   Kang, Jiman ^a   Stahl, Martin ^c   Han, Jiahuai ^d   Xiao, Changchun ^a   Vallance, Bruce A ^c   Kang, Young Jun ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c BC CHILDREN S HOSPITAL   (Canada)

^d XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 14;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GENOME; BACTERIAL INFECTION; CELL SPECIFICITY; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM CELL; LYMPHOCYTIC INFILTRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; CITROBACTER RODENTIUM; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; ENZYME ACTIVATION; EPITHELIAL CELLS; FLOW CYTOMETRY; GASTROENTERITIS; IMMUNITY, MUCOSAL; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 14; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84883367276     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300908     Document Type: Article

References (47)

1. Mundy, R., T. T. MacDonald, G. Dougan, G. Frankel, and S. Wiles. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7: 1697-1706.
2. Bry, L., and M. B. Brenner. 2004. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J. Immunol. 172: 433-441.
3. Bry, L., M. Brigl, and M. B. Brenner. 2006. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect. Immun. 74: 673-681.
4. Lebeis, S. L., B. Bommarius, C. A. Parkos, M. A. Sherman, and D. Kalman. 2007. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 179: 566-577.
5. Maaser, C., M. P. Housley, M. Iimura, J. R. Smith, B. A. Vallance, B. B. F. Inlay, J. R. Schreiber, N. M. Varki, M. F. Kagnoff, and L. Eckmann. 2004. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72: 3315-3324.
6. Simmons, C. P., N. S. Goncalves, M. Ghaem-Maghami, M. Bajaj-Elliott, S. Clare, B. Neves, G. Frankel, G. Dougan, and T. T. MacDonald. 2002. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J. Immunol. 168: 1804-1812.
7. Gibson, D. L., C. Ma, C. M. Rosenberger, K. S. Bergstrom, Y. Valdez, J. T. Huang, M. A. Khan, and B. A. Vallance. 2008. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentiuminduced colitis. Cell. Microbiol. 10: 388-403.
8. Geddes, K., S. J. Rubino, J. G. Magalhaes, C. Streutker, B. L. Le, J. H. Cho, S. J. Robertson, C. J. Kim, R. Kaul, D. J. Philpott, and S. E. Girardin. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17: 837-844.
9. Kim, Y. G., N. Kamada, M. H. Shaw, N. Warner, G. Y. Chen, L. Franchi, and G. Nunez. 2011. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34: 769-780.
10. MacDonald, T. T., G. Frankel, G. Dougan, N. S. Goncalves, and C. Simmons. 2003. Host defences to Citrobacter rodentium. Int. J. Med. Microbiol. 293: 87-93.
11. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
12. Zaph, C., A. E. Troy, B. C. Taylor, L. D. Berman-Booty, K. J. Guild, Y. Du, E. A. Yost, A. D. Gruber, M. J. May, F. R. Greten, et al. 2007. Epithelial-cellintrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446: 552-556.
13. Goncalves, N. S., M. Ghaem-Maghami, G. Monteleone, G. Frankel, G. Dougan, D. J. Lewis, C. P. Simmons, and T. T. MacDonald. 2001. Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect. Immun. 69: 6651-6659.
14. Ono, K., and J. Han. 2000. The p38 signal transduction pathway: activation and function. Cell. Signal. 12: 1-13.
15. Rincon, M., and R. J. Davis. 2009. Regulation of the immune response by stressactivated protein kinases. Immunol. Rev. 228: 212-224.
16. Cook, R., C. C. Wu, Y. J. Kang, and J. Han. 2007. The role of the p38 pathway in adaptive immunity. Cell. Mol. Immunol. 4: 253-259.
17. Kang, Y. J., J. Chen, M. Otsuka, J. Mols, S. Ren, Y. Wang, and J. Han. 2008. Macrophage deletion of p38alpha partially impairs lipopolysaccharide- induced cellular activation. J. Immunol. 180: 5075-5082.
18. Kim, C., Y. Sano, K. Todorova, B. A. Carlson, L. Arpa, A. Celada, T. Lawrence, K. Otsu, J. L. Brissette, J. S. Arthur, and J. M. Park. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9: 1019-1027.
19. Ritprajak, P., M. Hayakawa, Y. Sano, K. Otsu, and J. M. Park. 2012. Cell typespecific targeting dissociates the therapeutic from the adverse effects of protein kinase inhibition in allergic skin disease. Proc. Natl. Acad. Sci. USA 109: 9089-9094.
20. Otsuka, M., Y. J. Kang, J. Ren, H. Jiang, Y. Wang, M. Omata, and J. Han. 2010. Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 138: 1255-65.
21. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17: 2817-2829.
22. Noubade, R., D. N. Krementsov, R. R. Del, T. Thornton, V. Nagaleekar, N. Saligrama, A. Spitzack, K. Spach, G. Sabio, R. J. Davis, et al. 2011. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 118: 3290-3300.
23. Jirmanova, L., M. L. Giardino Torchia, N. D. Sarma, P. R. Mittelstadt, and J. D. Ashwell. 2011. Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation. Blood 118: 3280-3289.
24. Kang, Y. J., M. Otsuka, A. van den Berg, L. Hong, Z. Huang, X. Wu, D. W. Zhang, B. A. Vallance, P. S. Tobias, and J. Han. 2010. Epithelial p38alpha controls immune cell recruitment in the colonic mucosa. PLoS Pathog. 6: e1000934.
25. Chen, C. C., S. Louie, B. McCormick, W. A. Walker, and H. N. Shi. 2005. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect. Immun. 73: 5468-5481.
26. Wu, X., B. A. Vallance, L. Boyer, K. S. Bergstrom, J. Walker, K. Madsen, J. R. O'Kusky, A. M. Buchan, and K. Jacobson. 2008. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G295-G306.
27. Masuda, A., M. Yoshida, H. Shiomi, S. Ikezawa, T. Takagawa, H. Tanaka, R. Chinzei, T. Ishida, Y. Morita, H. Kutsumi, et al. 2008. Fcgamma receptor regulation of Citrobacter rodentium infection. Infect. Immun. 76: 1728-1737.
28. Jirmanova, L., D. N. Sarma, D. Jankovic, P. R. Mittelstadt, and J. D. Ashwell. 2009. Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production. Blood 113: 2229-2237.
29. MacDonald, T. T., and G. Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307: 1920-1925.
30. Guma, M., D. Stepniak, H. Shaked, M. E. Spehlmann, S. Shenouda, H. Cheroutre, I. Vicente-Suarez, L. Eckmann, M. F. Kagnoff, and M. Karin. 2011. Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. J. Exp. Med. 208: 1889-1900.
31. Campbell, D. J., and E. C. Butcher. 2002. Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine. J. Clin. Invest. 110: 1079-1081.
32. Agace, W. W. 2008. T-cell recruitment to the intestinal mucosa. Trends Immunol. 29: 514-522.
33. Dennis, A., T. Kudo, L. Kruidenier, F. Girard, V. F. Crepin, T. T. MacDonald, G. Frankel, and S. Wiles. 2008. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium. Infect. Immun. 76: 4978-4988.
34. Nenci, A., C. Becker, A. Wullaert, R. Gareus, L. G. Van, S. Danese, M. Huth, A. Nikolaev, C. Neufert, B. Madison, et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561.
35. Khan, M. A., C. Ma, L. A. Knodler, Y. Valdez, C. M. Rosenberger, W. Deng, B. B. F. Inlay, and B. A. Vallance. 2006. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect. Immun. 74: 2522-2536.
36. Higgins, L. M., G. Frankel, G. Douce, G. Dougan, and T. T. MacDonald. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67: 3031-3039.
37. Spahn, T. W., and M. Ross, E. C. von, C. Maaser, T. Spieker, K. Kannengiesser, W. Domschke, and T. Kucharzik. 2008. CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity. Scand. J. Immunol. 67: 238-244.
38. Symonds, E. L., C. U. Riedel, D. O'Mahony, S. Lapthorne, L. O'Mahony, and F. Shanahan. 2009. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clin. Exp. Immunol. 157: 148-154.
39. Gulen, M. F., Z. Kang, K. Bulek, W. Youzhong, T. W. Kim, Y. Chen, C. Z. Altuntas, K. Sass Bak-Jensen, M. J. McGeachy, J. S. Do, et al. 2010. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32: 54-66.
40. Li, L., J. Kim, and V. A. Boussiotis. 2010. IL-1beta-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. J. Immunol. 185: 4148-4153.
41. Huang, G., Y. Wang, P. Vogel, T. D. Kanneganti, K. Otsu, and H. Chi. 2012. Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat. Immunol. 13: 152-161.
42. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363.
43. Shiomi, H., A. Masuda, S. Nishiumi, M. Nishida, T. Takagawa, Y. Shiomi, H. Kutsumi, R. S. Blumberg, T. Azuma, and M. Yoshida. 2010. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect. Immun. 78: 2653-2666.
44. Rubino, S. J., K. Geddes, and S. E. Girardin. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33: 112-118.
45. Lacroix-Lamande, S., R. Mancassola, M. Naciri, and F. Laurent. 2002. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Infect. Immun. 70: 2090-2099.
46. Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J. M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827-G838.
47. Serna, A., and E. C. Boedeker. 2008. Pathogenesis and treatment of Shiga toxinproducing Escherichia coli infections. Curr. Opin. Gastroenterol. 24: 38-47.